Search
After years of neglect, I’m glad to see Congress give drug safety the attention it deserves. Last week, Reps. John D. Dingell (D-MI 15), Frank Pallone, Jr. (D-NJ 06) and Bart Stupak (D-MI 01) introduced the Food and Drug Administration Globalization Act of 2009 (H.R.759). In addition to addressing several food safety issues, the proposed legislation addresses the real threat of substandard and counterfeit drugs.
Read MoreMainland authorities have found more than 5,000 bottles of fake diabetes medication in two provinces that last month were blamed for the deaths of two patients, state media said. The patients died in Xinjiang. Now the government has found the same fake drug in Sichuan and Qinghai, state radio said. But nobody has yet been found to have fallen sick…
Read MorePharmaceutical industry officials in Kenya estimate that at least 40 percent of the drugs sold in the East African nation are counterfeit, with anti-malarial drugs being especially susceptible to being faked. Patients continue to be sick or can even die as a result of taking counterfeit drugs, most are believed to originate from China and India. By Cathy Majtenyi 4…
Read MoreURUMQI, Feb. 3 (Xinhua) — Nine people were hospitalized after taking a counterfeit diabetes drug in northwest China's Xinjiang Uygur Autonomous Region that last month caused the death of two others, said the local government Tuesday. Four of the nine people were being treated in Kashi People's Hospital and are in stable condition. Five others had been released from hospital,…
Read MoreThirty-thousand packs of fake life-saving drugs may have been consumed by NHS patients, the BBC has learned. A senior official from the government's medicines watchdog said the case must lead to tightening of the law.
Read MoreIndustry Resources on Counterfeit Drugs The battle against fake medicines involves a variety of industry stakeholders–from the legitimate manufacturers of medicine, to the wholesale distributors that transport them, and to the pharmacies that dispense them. As the issue of counterfeit medicines grows in importance internationally, industry groups and firms are focusing on consumer education to avoid counterfeits. Manufacturers’ Consumer Education…
Read MoreNon-Profit Initiatives Problems of counterfeit, contraband and otherwise unsafe medicines require participation and collaboration among many sectors, including public health professionals, patients, the business community, and academic experts. This page provides a guide to those organizations. For a more exhaustive list of these organizations’ policy positions, please visit our Position Papers page in the expert section. If you would like…
Read MorePosition Papers, Reports & Guidelines This page lists white papers, best practices, guidelines, and other relevant documents for fight against counterfeit medicines. AIM Anti-Counterfeiting Committee. Customs and Rightholders: The best of partners need the best of practices. Brussels, June 2007. AIPM/CIPR. “Action Plan to Fight Counterfeit Medicines in Russia.” The Association of International Pharmaceutical Manufacturers and Coalition for Intellectual Property…
Read More